ASMB Company Profile and Key Details

Q: Who are the executives of ASMB?

Dr. William E. Delaney IV, Ph.D.Chief Scientific OfficerMs. Michele AndersonChief Devel. OfficerAmy Figueroa C.F.A.Investor Relations ConsultantDr. John G. McHutchison A.O., FRACP, M.D.Chief Executive Officer & DirectorMs. Jennifer A. Troia MHROD, SHRM-SCP, SPHRChief HR OfficerDr. Adam ZlotnickCo-Founder, Chief Scientific Advisor and Chair of Hbv & Virology Science Advisory BoardMr. Jason A. OkazakiChief Operating Officer, Chief Executive Officer, Pres & DirectorMr. Thomas E. RollinsExecutive OfficerDr. Tharaknath RaoHead of Microbiome Clinical Devel. & Senior Vice PresidentDr. Nicole S. White Ph.D.Chief Manufacturing OfficerDr. Richard J. ColonnoSenior AdvisorJeanette M BjorkquistExecutive Director of Accounting & TreasuryShannon RyanSenior Vice President of Investor Relations, Corporation Affairs & Alliance Management

NASDAQ : ASMB

Assembly Biosciences

$29.69

0.555+1.91%

Open: 12:16 PM

57.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Assembly Biosciences, Inc. (ASMB) stock surged +1.91%, trading at $29.69 on NASDAQ, up from the previous close of $29.13. The stock opened at $29.17, fluctuating between $29.08 and $30.02 in the recent session.

Stock Snapshot

29.13

Prev. Close

469.53M

Market Cap

29.08

Day Low

-6.45

P/E Ratio

-4.6

EPS (TTM)

4.1

Cash Flow per Share

29.17

Open

15.82M

Number of Shares

30.02

Day High

46.84%

Free Float in %

7.5

Book Value

15.53K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 09, 2026	28.01	29.72	28.01	29.13	103.28K
Mar 06, 2026	27.19	29.00	27.00	28.27	90.65K
Mar 03, 2026	28.70	29.00	27.87	28.80	54K
Mar 02, 2026	29.33	30.25	29.07	29.68	61.66K
Feb 27, 2026	29.07	30.62	28.64	29.84	129.7K
Feb 26, 2026	29.56	29.77	28.49	29.59	89.5K
Feb 25, 2026	29.69	30.40	29.16	29.34	75.57K
Feb 24, 2026	30.16	30.20	29.30	29.64	94.83K
Feb 23, 2026	28.40	30.10	28.22	29.95	137.29K
Feb 20, 2026	26.03	29.01	26.02	28.75	136.85K
Feb 19, 2026	29.26	29.46	25.72	25.97	399.94K
Feb 18, 2026	27.76	28.93	27.76	28.89	72.34K
Feb 17, 2026	26.69	27.86	26.00	27.82	78.2K
Feb 13, 2026	26.09	27.32	25.92	26.66	83.85K
Feb 12, 2026	27.40	27.40	25.47	26.09	101.5K
Feb 11, 2026	27.39	27.50	26.08	27.36	61.47K
Feb 10, 2026	26.91	27.48	26.32	27.48	54.76K
Feb 09, 2026	26.75	27.48	26.00	26.90	69.86K
Feb 06, 2026	25.62	26.80	25.58	26.22	56.05K
Feb 05, 2026	27.22	27.84	25.14	25.39	98.78K

Contact Details

South San Francisco, CA 94080

United States

https://www.assemblybio.com 833 509 4583

About Company

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Stock Peers

REGN

21.74+2.86%

Regeneron Pharmaceuticals, Inc.$781.60 ARGX

22.6+3.15%

argenx SE$740.40 UTHR

51.01+10.67%

United Therapeutics Corporation$529.17 VRTX

4.18+0.92%

Vertex Pharmaceuticals Incorporated$460.87 MDGL

0.37+0.09%

Madrigal Pharmaceuticals, Inc.$433.20 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

2.93+0.91%

Alnylam Pharmaceuticals, Inc.$323.59 PRAX

-1.7-0.55%

Praxis Precision Medicines, Inc.$309.01 KRYS

4.96+1.96%

Krystal Biotech, Inc.$258.65 ASND

-0.73-0.30%

Ascendis Pharma A/S$239.92

Frequently Asked Questions

What is the current Assembly Biosciences, Inc. (ASMB) stock price?

Assembly Biosciences, Inc. (NASDAQ: ASMB) stock price is $29.69 in the last trading session. During the trading session, ASMB stock reached the peak price of $30.02 while $29.08 was the lowest point it dropped to. The percentage change in ASMB stock occurred in the recent session was 1.91% while the dollar amount for the price change in ASMB stock was $0.56.

ASMB's industry and sector of operation?

The NASDAQ listed ASMB is part of Biotechnology industry that operates in the broader Healthcare sector. Assembly Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ASMB?

Dr. William E. Delaney IV, Ph.D.
Chief Scientific Officer
Ms. Michele Anderson
Chief Devel. Officer
Amy Figueroa C.F.A.
Investor Relations Consultant
Dr. John G. McHutchison A.O., FRACP, M.D.
Chief Executive Officer & Director
Ms. Jennifer A. Troia MHROD, SHRM-SCP, SPHR
Chief HR Officer
Dr. Adam Zlotnick
Co-Founder, Chief Scientific Advisor and Chair of Hbv & Virology Science Advisory Board
Mr. Jason A. Okazaki
Chief Operating Officer, Chief Executive Officer, Pres & Director
Mr. Thomas E. Rollins
Executive Officer
Dr. Tharaknath Rao
Head of Microbiome Clinical Devel. & Senior Vice President
Dr. Nicole S. White Ph.D.
Chief Manufacturing Officer
Dr. Richard J. Colonno
Senior Advisor
Jeanette M Bjorkquist
Executive Director of Accounting & Treasury
Shannon Ryan
Senior Vice President of Investor Relations, Corporation Affairs & Alliance Management

How ASMB did perform over past 52-week?

ASMB's closing price is 275.87% higher than its 52-week low of $7.75 where as its distance from 52-week high of $39.71 is -26.64%.

How many employees does ASMB have?

Number of ASMB employees currently stands at 73.

Link for ASMB official website?

Official Website of ASMB is: https://www.assemblybio.com

How do I contact ASMB?

ASMB could be contacted at phone 833 509 4583 and can also be accessed through its website. ASMB operates from 331 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

How many shares of ASMB are traded daily?

ASMB stock volume for the day was 15.53K shares. The average number of ASMB shares traded daily for last 3 months was 120.65K.

What is the market cap of ASMB currently?

The market value of ASMB currently stands at $469.53M with its latest stock price at $29.69 and 15.82M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	73
Beta	1.16
Sales or Revenue	$7.16M
5Y Sales Change%	1.41%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	73
Beta	1.16
Sales or Revenue	$7.16M
5Y Sales Change%	1.41%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ASMB Company Profile and Key Details

Assembly Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook